Crisis Interventions for Pediatric Providers - Autism Version
Safety Planning for Autistic Youth: A Randomized Controlled Trial With Providers in Pediatric Clinics
2 other identifiers
interventional
70
1 country
1
Brief Summary
The goal of this clinical trial is to examine the initial feasibility, acceptability, and effectiveness of Crisis Interventions for Pediatric Providers - Autism version (CIPP-A) for providers serving autistic youth in outpatient settings. The main question aims to answer:
- Assess whether CIPP-A is feasible and acceptable to providers in development behavioral pediatric clinics?
- Assess whether CIPP-A shows initial effectiveness in increasing providers confidence in managing suicide risk in autistic youth? If there is a comparison group: Researchers will compare CIPP-A to general safety planning intervention (SPI) on feasibility, acceptability, and initial effectiveness. Participants will be randomized to receive training in SPI or CIPP-A and complete online surveys and interviews over 6-months to measure feasibility, acceptability, and initial effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2026
CompletedFirst Posted
Study publicly available on registry
April 2, 2026
CompletedStudy Start
First participant enrolled
December 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2028
Study Completion
Last participant's last visit for all outcomes
December 31, 2028
April 13, 2026
April 1, 2026
1.8 years
March 27, 2026
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility: Number of times that providers use SPI or CIPP-A in 6 months
The feasibility of SPI and CIPP-A will be assessed by an online survey of the number of times that providers used SPI/CIPP-A with autistic patients in 6 months. Higher scores indicate greater feasibility and use of SPI/CIPP-A (i.e., better outcome).The survey will be administered three times from baseline to 6 months.
Baseline to 6 months
Acceptability: Acceptability of Intervention Measure
The Acceptability of Intervention Measure (AIM) will be administered to providers to assess perceived acceptability of SPI and CIPP-A. The AIM is a widely used measure of the extent to which stakeholders believe an intervention is satisfactory in a given setting (e.g., "I like SPI"). The AIM items are scored on a 5-point scale (1, completely disagree to 5, completely agree), with total scores ranging from 5-25. Higher scores indicate greater acceptability (i.e., better outcome). The AIM will be administered three times from baseline to 6 months.
Baseline to 6 months
Initial Effectiveness: Providers confidence in using SPI or CIPP-A
A series of visual analog scales (VAS; 0-100%) will be used to measure changes in providers' confidence in managing patient crises over the study, with total scores ranging from 0-100. Higher scores indicate greater effectiveness (i.e., better outcome). The VAS will be administered three times from baseline to 6 months.
Baseline to 6 months
Secondary Outcomes (3)
Feasibility of Intervention Measure
Baseline to 6 months
Fidelity of implementation
6 months
Semi-structured interview to assess intervention feasibility
6 months
Study Arms (2)
Safety Planning Intervention
ACTIVE COMPARATORThe SPI is a brief, evidence-based suicide prevention intervention for youth and adults that can be delivered by diverse providers.
Crisis Interventions for Pediatric Providers - Autism version (CIPP-A)
EXPERIMENTALThe CIPP-A is a brief suicide prevention intervention for youth and adults that can be delivered by diverse providers and has been adapted for autistic youth.
Interventions
The Safety Planning Intervention (SPI) is leading, evidence-based intervention that manages risks associated with suicidal thoughts and behaviors in youth. The SPI is delivered by providers to youth and their parents/guardians and focuses on teaching the family a series of safety planning steps to keep youth safe as they experience suicidal thoughts and/or behaviors. The SPI can be delivered by providers to families in person or virtually during clinic visits, and shows effectiveness in increasing child safety. Further, the SPI is a flexible intervention that can be delivered by a variety of healthcare professionals (e.g., pediatricians, social workers, nurses, etc.). The SPI has been found to be effective when delivered in emergency, inpatient, and outpatient settings; in this study, the SPI will be delivered by providers in Developmental-Behavioral Pediatric (DBP) settings.
The CIPP-A is an autism-specific crisis intervention for pediatric providers co-developed by the PI (licensed psychologist) and autistic people, which was published in Pediatrics. Similar to the SPI, CIPP-A is delivered by providers to youth and their parents and focuses on teaching the family a series of crisis interventions to keep youth safe as they experience suicidal thoughts and/or behaviors, with autism-specific adaptations. Autism-specific adaptations include warning signs (e.g., sensory overload, social burnout) that may be unique to this population, as well as coping skills (e.g., quiet time alone in sensory friendly environment, engagement in preferred interests). The CIPP-A contains an overview of autism and how suicidal thoughts/behaviors may present differently in this population. The CIPP-A can be delivered by providers to families in person or virtually during clinic visits. Further, the CIPP-A is can be flexibly delivered by a variety of healthcare professionals.
Eligibility Criteria
You may qualify if:
- Pediatric healthcare providers serving autistic youth in a DBP clinic in the U.S.
- Willing and able to participate in the study and its activities, including remote training in either SPI or CIPP-A (depending on randomization)
- Willing and able to provide informed consent
- Comfortable speaking or communicating in English
You may not qualify if:
- Pediatric healthcare providers not serving autistic youth
- Pediatric healthcare providers not practicing in a DBP clinic in the U.S.
- Unwilling and unable to participate in the study and its activities
- Unwilling and unable to provide informed consent
- Not comfortable speaking or communicating in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Schwartzman, PhD
Children's Hospital Los Angeles
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Staff/USC Faculty CWR
Study Record Dates
First Submitted
March 27, 2026
First Posted
April 2, 2026
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
August 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share